Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
3.760
+0.110 (3.01%)
Oct 16, 2026, 9:51 AM EDT - Market open
Cryo-Cell International Financials Overview
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Revenue Revenue Growth | 31.13 | 31.57 | 31.99 | 31.34 | 30.34 | 28.88 |
Revenue Growth | -1.96% | -1.31% | 2.05% | 3.32% | 5.03% | -7.26% |
Gross Profit Gross Profit Growth | 20.09 | 19.83 | 24.04 | 19.22 | 21.54 | 18.73 |
Operating Income Operating Income Growth | 0.19 | 0.48 | 3.79 | -0.25 | 4.46 | 3.24 |
Net Income Net Income Growth | -1.95 | -2.43 | 0.4 | -9.52 | 2.77 | 2.08 |
Earnings Per Share EPS Growth | -0.24 | -0.30 | 0.05 | -1.14 | 0.33 | 0.25 |
EPS Growth | - | - | - | - | 30.95% | -44.44% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Umbilical Cord Blood and Cord Tissue Stem Cell Service Umbilical Cord Blood and Cord Tissue Stem Cell Service Growth | 30.83 | 31.38 | 31.55 | 30.8 | 29.77 | 28.4 |
Public Cord Blood Banking Public Cord Blood Banking Growth | 0.18 | 0.13 | 0.37 | 0.48 | 0.46 | 0.38 |
Prepacyte CB Prepacyte CB Growth | 0.11 | 0.05 | 0.07 | 0.07 | 0.1 | 0.11 |
Total Total Growth | 31.13 | 31.57 | 31.99 | 31.34 | 30.34 | 28.88 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Cash & Investments Cash & Investments Growth | 4.23 | 3.3 | 3.5 | 1.1 | 1.72 | 8.34 |
Total Debt Total Debt Growth | 8.82 | 11.56 | 12.93 | 10.9 | 11.61 | 2.82 |
Net Cash (Debt) Net Cash Growth | -4.59 | -8.26 | -9.44 | -9.79 | -9.89 | 5.52 |
Net Cash Growth | - | - | - | - | - | 31.08% |
Net Cash Per Share Net Cash Per Share Growth | -0.57 | -1.02 | -1.15 | -1.17 | -1.17 | 0.66 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 4.92 | 5.48 | 6.01 | 8.92 | 8.57 | 7.93 |
Capital Expenditures CapEx Growth | -0.27 | -0.23 | -2.4 | -6.84 | -12.17 | -1.83 |
Free Cash Flow Free Cash Flow Growth | 4.65 | 5.25 | 3.61 | 2.08 | -3.6 | 6.09 |
Free Cash Flow Growth | -24.77% | 45.49% | 73.36% | - | - | -27.19% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Gross Margin | 64.53% | 62.82% | 75.15% | 61.31% | 71.02% | 64.85% |
Operating Margin | 0.61% | 1.53% | 11.84% | -0.79% | 14.70% | 11.20% |
Pretax Margin | -6.13% | -7.40% | 8.77% | -42.64% | 10.94% | 9.04% |
Profit Margin | -6.25% | -7.70% | 1.26% | -30.38% | 9.13% | 7.21% |
FCF Margin | 14.94% | 16.63% | 11.28% | 6.64% | -11.85% | 21.09% |
| Fiscal Year | FY 2025 | FY 2024 |
|---|---|---|
| Period Ending | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 |
Dividend Per Share Dividend Per Share Growth | 0.400 | 0.250 |
Dividend Per Share Growth | 60.00% | - |
Dividend Yield | 9.30% | 2.89% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 16, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
PE Ratio | - | - | 173.84 | - | 13.43 | 50.68 |
Forward PE | 47.50 | 56.00 | 78.82 | 252.00 | 48.56 | - |
P/FCF Ratio | 6.33 | 6.60 | 19.38 | 21.31 | - | 17.33 |
PS Ratio | 0.95 | 1.10 | 2.19 | 1.41 | 1.23 | 3.66 |